Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction

ST-elevation myocardial infarction (STEMI) is one of the main reasons for morbidity and mortality worldwide. In addition to the classic biomarker NT-proBNP, new biomarkers like ST2 and Pentraxin-3 (Ptx-3) have emerged as potential tools in stratifying risk in cardiac patients. Indeed, multimarker ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagidullin, Naufal, Motloch, Lukas J., Gareeva, Diana, Hamitova, Aysilu, Lakman, Irina, Krioni, Ilja, Popov, Denis, Zulkarneev, Rustem, Paar, Vera, Kopp, Kristen, Jirak, Peter, Ishmetov, Vladimir, Hoppe, Uta C., Tulbaev, Eduard, Pavlov, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073894/
https://www.ncbi.nlm.nih.gov/pubmed/32085400
http://dx.doi.org/10.3390/jcm9020550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073894/
https://www.ncbi.nlm.nih.gov/pubmed/32085400
http://dx.doi.org/10.3390/jcm9020550

Ejemplares similares